2019 nCoV (SARS CoV2 coronavirus) Ad-2019nCoV-Spike(S1+S2)- S477N mutation(The B.1.526 lineage; 20A.EU2) Pre-made adenovirus
Cat No.:GMV-V-2019nCoV-139
Order information
| Package | Catalog No. | Price(In USD) | Qty (Quantity) | Sum(In USD) | 
|---|---|---|---|---|
| GMV-V-2019nCoV-139 | In vitro grade: 1E+10PFU (1E+10pfu/ml×1ml) | 3390 | ||
| GMV-V-2019nCoV-139 | In vitro grade: 5E+10PFU (1E+10pfu/ml×5ml) | 4990 | ||
| GMV-V-2019nCoV-139 | In vitro grade: 1E+11PFU (1E+10pfu/ml×10ml) | 9090 | ||
| GMV-V-2019nCoV-139 | Large size | Inquiry. | ||
| GMV-V-2019nCoV-139 | In vivo grade: 1E+11PFU (1E+11pfu/ml×1ml) | Inquiry. | ||
| Shipping Cost: | 760.00 | |||
| Total: | ||||
Description
| 2019 nCoV related Gene | Spike(S1+S2)- S477N mutation(The B.1.526 lineage; 20A.EU2) | 
| Species Host | (The B.1.526 lineage; 20A.EU2 lineage | 
| Vector | Pre-made adenovirus | 
| Reporter | null | 
| Antibiotic in Mammalian cell | null | 
| Length | 3822 | 
| Promoter | CMV | 
| Tag | C-3FLAG | 
| Codon Optimized | Codon Optimized for mamamlian | 
| Gene Accession Number | QHD43416.1 | 
| Application | Adenovirus-based 2019nCoV vaccine; Adenovirus production; Mammalian cells expression | 
        <
                
                
            
        
        

